Here, we reported that PHN combined with autophagy blockers could produce anti-tumor effects at least partially through inhibition of autophagy via AMPK/mTOR/p70S6K signaling pathway, suggesting that combining use of PHN and an autophagy blocker might serve as a novel strategy against LSCC. The gene discussed is MTOR; the disease is neoplasm.